Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - TOTAL DEBT REPAID
Total Debt Repaid AVTX - Avalo Therapeutics, Inc.
-21.2 M
LAST VALUE
-28.29%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR